Clinical Trial Detail

NCT ID NCT03211988
Title Entinostat Neuroendocrine (NE) Tumor
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Edward Gelmann
Indications

neuroendocrine tumor

Therapies

Entinostat

Age Groups: adult senior

No variant requirements are available.